Holen Sie sich die Stockscreener-App
6.8101
1.16%
-0.1099
Schlusskurs vom Vortag:
$6.92
Offen:
$7
24-Stunden-Volumen:
181.87K
Relative Volume:
0.54
Marktkapitalisierung:
$600.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.63M
KGV:
-12.90
EPS:
-0.5281
Netto-Cashflow:
$-39.43M
1W Leistung:
+4.43%
1M Leistung:
+6.71%
6M Leistung:
+62.09%
1J Leistung:
+171.43%
1-Tages-Spanne:
$6.80
$7.17
1-Wochen-Bereich:
$6.70
$7.30
52-Wochen-Spanne:
$2.4324
$8.60
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Firmenname
Alpha Tau Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare DRTS vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
6.82 | 609.03M | 0 | -42.63M | -39.43M | -0.5281 |
VRTX
Vertex Pharmaceuticals Inc
|
433.58 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.40 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.05 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.89 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.74 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | Eingeleitet | Citigroup | Buy |
| 2023-04-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-04 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
DRTS SEC FilingsAlpha Tau Medical Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Alpha Emitter Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - investing.com
Stop Loss: How does Alpha Tau Medical Ltd compare to its peersTrade Signal Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW - TipRanks
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Aug Update: What is Alpha Tau Medical Ltd Equity Warrants market position2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - tipranks.com
Aug EndMonth: Why is Alpha Tau Medical Ltd stock going down2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
Alpha Tau Medical (Nasdaq: DRTS) wins DDW 2026 oral slot for Alpha DaRT pancreatic cancer trials - Stock Titan
Pancreatic cancer trial data from Jerusalem lands DDW podium slot - Stock Titan
Resistance Check: Is Alpha Tau Medical Ltd forming a bullish divergenceDollar Strength & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Spikes: Should I invest in Alpha Tau Medical Ltd before earningsWeekly Trading Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Aug Ideas: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M AQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
US Stocks Recap: What is Alpha Tau Medical Ltd Equity Warrants market positionMarket Movers & Community Verified Trade Signals - baoquankhu1.vn
Alpha Tau Medical Ltd. (DRTS) Competitors - Meyka
Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha
What is the Moat Score of Alpha Tau Medical Ltd2026 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Aug Action: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changes2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Is Alpha Tau Medical Ltd forming a bullish divergence2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpHere's Why - MarketBeat
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased - MarketBeat
Resistance Check: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changesRate Hike & Daily Volume Surge Signals - baoquankhu1.vn
Alpha Tau Medical (DRTS) director details shares, options and RSUs - Stock Titan
Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan
Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings - Stock Titan
Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan
Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan
Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan
Pullback Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Aug EndMonth: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandPortfolio Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd stock showing strong momentum2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Recap: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly priced2026 Trading Volume Trends & Weekly Stock Breakout Alerts - baoquankhu1.vn
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewswire
Citigroup maintains Alpha Tau Medical (DRTS) buy recommendation - MSN
CFO Raphi Levy to pitch Alpha Tau to investors at Sidoti event this week - Stock Titan
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Nigeria
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Fund Flows: What is the PEG ratio of Alpha Tau Medical Ltd2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Finanzdaten der Alpha Tau Medical Ltd-Aktie (DRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):